Cargando…

Evaluation of reader performance during interpretation of breast cancer screening: the Recall and detection Of breast Cancer in Screening (ROCS) trial study design

ABSTRACT: The magnitude of the tradeoff between recall rate (RR) and cancer detection rate (CDR) in breast-cancer screening is not clear, and it is expected to depend on target population and screening program characteristics. Multi-reader multi-case research studies, which may be used to estimate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sechopoulos, Ioannis, Abbey, Craig K., van der Waal, Daniëlle, Geertse, Tanya, Tetteroo, Eric, Pijnappel, Ruud M., Broeders, Mireille J.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668759/
https://www.ncbi.nlm.nih.gov/pubmed/35482123
http://dx.doi.org/10.1007/s00330-022-08820-5
_version_ 1784831983371681792
author Sechopoulos, Ioannis
Abbey, Craig K.
van der Waal, Daniëlle
Geertse, Tanya
Tetteroo, Eric
Pijnappel, Ruud M.
Broeders, Mireille J.M.
author_facet Sechopoulos, Ioannis
Abbey, Craig K.
van der Waal, Daniëlle
Geertse, Tanya
Tetteroo, Eric
Pijnappel, Ruud M.
Broeders, Mireille J.M.
author_sort Sechopoulos, Ioannis
collection PubMed
description ABSTRACT: The magnitude of the tradeoff between recall rate (RR) and cancer detection rate (CDR) in breast-cancer screening is not clear, and it is expected to depend on target population and screening program characteristics. Multi-reader multi-case research studies, which may be used to estimate this tradeoff, rely on enriched datasets with artificially high prevalence rates, which may bias the results. Furthermore, readers participating in research studies are subject to “laboratory” effects, which can alter their performance relative to actual practice. The Recall and detection Of breast Cancer in Screening (ROCS) trial uses a novel data acquisition system that minimizes these limitations while obtaining an estimate of the RR-CDR curve during actual practice in the Dutch National Breast Cancer Screening Program. ROCS involves collection of at least 40,000 probability-of-malignancy ratings from at least 20 radiologists during interpretation of approximately 2,000 digital mammography screening cases each. With the use of custom-built software on a tablet, and a webcam, this data was obtained in the usual reading environment with minimal workflow disruption and without electronic access to the review workstation software. Comparison of the results to short- and medium-term follow-up allows for estimation of the RR-CDR and receiver operating characteristics curves, respectively. The anticipated result of the study is that performance-based evidence from practice will be available to determine the optimal operating point for breast-cancer screening. In addition, this data will be useful as a benchmark when evaluating the impact of potential new screening technologies, such as digital breast tomosynthesis or artificial intelligence. KEY POINTS: • The ROCS trial aims to estimate the recall rate–cancer detection rate curve during actual screening practice in the Dutch National Breast Cancer Screening Program. • The study design is aimed at avoiding the influence of the “laboratory effect” in usual observer performance studies. • The use of a tablet and a webcam allows for the acquisition of probability of malignancy ratings without access to the review workstation software. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-022-08820-5.
format Online
Article
Text
id pubmed-9668759
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-96687592022-11-18 Evaluation of reader performance during interpretation of breast cancer screening: the Recall and detection Of breast Cancer in Screening (ROCS) trial study design Sechopoulos, Ioannis Abbey, Craig K. van der Waal, Daniëlle Geertse, Tanya Tetteroo, Eric Pijnappel, Ruud M. Broeders, Mireille J.M. Eur Radiol Breast ABSTRACT: The magnitude of the tradeoff between recall rate (RR) and cancer detection rate (CDR) in breast-cancer screening is not clear, and it is expected to depend on target population and screening program characteristics. Multi-reader multi-case research studies, which may be used to estimate this tradeoff, rely on enriched datasets with artificially high prevalence rates, which may bias the results. Furthermore, readers participating in research studies are subject to “laboratory” effects, which can alter their performance relative to actual practice. The Recall and detection Of breast Cancer in Screening (ROCS) trial uses a novel data acquisition system that minimizes these limitations while obtaining an estimate of the RR-CDR curve during actual practice in the Dutch National Breast Cancer Screening Program. ROCS involves collection of at least 40,000 probability-of-malignancy ratings from at least 20 radiologists during interpretation of approximately 2,000 digital mammography screening cases each. With the use of custom-built software on a tablet, and a webcam, this data was obtained in the usual reading environment with minimal workflow disruption and without electronic access to the review workstation software. Comparison of the results to short- and medium-term follow-up allows for estimation of the RR-CDR and receiver operating characteristics curves, respectively. The anticipated result of the study is that performance-based evidence from practice will be available to determine the optimal operating point for breast-cancer screening. In addition, this data will be useful as a benchmark when evaluating the impact of potential new screening technologies, such as digital breast tomosynthesis or artificial intelligence. KEY POINTS: • The ROCS trial aims to estimate the recall rate–cancer detection rate curve during actual screening practice in the Dutch National Breast Cancer Screening Program. • The study design is aimed at avoiding the influence of the “laboratory effect” in usual observer performance studies. • The use of a tablet and a webcam allows for the acquisition of probability of malignancy ratings without access to the review workstation software. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-022-08820-5. Springer Berlin Heidelberg 2022-04-28 2022 /pmc/articles/PMC9668759/ /pubmed/35482123 http://dx.doi.org/10.1007/s00330-022-08820-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Breast
Sechopoulos, Ioannis
Abbey, Craig K.
van der Waal, Daniëlle
Geertse, Tanya
Tetteroo, Eric
Pijnappel, Ruud M.
Broeders, Mireille J.M.
Evaluation of reader performance during interpretation of breast cancer screening: the Recall and detection Of breast Cancer in Screening (ROCS) trial study design
title Evaluation of reader performance during interpretation of breast cancer screening: the Recall and detection Of breast Cancer in Screening (ROCS) trial study design
title_full Evaluation of reader performance during interpretation of breast cancer screening: the Recall and detection Of breast Cancer in Screening (ROCS) trial study design
title_fullStr Evaluation of reader performance during interpretation of breast cancer screening: the Recall and detection Of breast Cancer in Screening (ROCS) trial study design
title_full_unstemmed Evaluation of reader performance during interpretation of breast cancer screening: the Recall and detection Of breast Cancer in Screening (ROCS) trial study design
title_short Evaluation of reader performance during interpretation of breast cancer screening: the Recall and detection Of breast Cancer in Screening (ROCS) trial study design
title_sort evaluation of reader performance during interpretation of breast cancer screening: the recall and detection of breast cancer in screening (rocs) trial study design
topic Breast
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668759/
https://www.ncbi.nlm.nih.gov/pubmed/35482123
http://dx.doi.org/10.1007/s00330-022-08820-5
work_keys_str_mv AT sechopoulosioannis evaluationofreaderperformanceduringinterpretationofbreastcancerscreeningtherecallanddetectionofbreastcancerinscreeningrocstrialstudydesign
AT abbeycraigk evaluationofreaderperformanceduringinterpretationofbreastcancerscreeningtherecallanddetectionofbreastcancerinscreeningrocstrialstudydesign
AT vanderwaaldanielle evaluationofreaderperformanceduringinterpretationofbreastcancerscreeningtherecallanddetectionofbreastcancerinscreeningrocstrialstudydesign
AT geertsetanya evaluationofreaderperformanceduringinterpretationofbreastcancerscreeningtherecallanddetectionofbreastcancerinscreeningrocstrialstudydesign
AT tetterooeric evaluationofreaderperformanceduringinterpretationofbreastcancerscreeningtherecallanddetectionofbreastcancerinscreeningrocstrialstudydesign
AT pijnappelruudm evaluationofreaderperformanceduringinterpretationofbreastcancerscreeningtherecallanddetectionofbreastcancerinscreeningrocstrialstudydesign
AT broedersmireillejm evaluationofreaderperformanceduringinterpretationofbreastcancerscreeningtherecallanddetectionofbreastcancerinscreeningrocstrialstudydesign